Welcome to LookChem.com Sign In|Join Free
  • or
2-Aminoimidazole is a versatile chemical compound that features an amino group and an imidazole group. It is recognized for its potential applications in various fields, including pharmaceuticals, agrochemicals, and the development of functional materials. 2-Aminoimidazole's ability to inhibit biofilm formation and disrupt cell membranes, along with its antioxidant and anti-inflammatory properties, positions it as a promising candidate for research and development in healthcare and related industries.

7720-39-0

Post Buying Request

7720-39-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7720-39-0 Usage

Uses

Used in Pharmaceutical Industry:
2-Aminoimidazole is used as a building block for the synthesis of various pharmaceuticals due to its chemical reactivity and potential to contribute to the development of new drugs with diverse therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Aminoimidazole is utilized as a component in the creation of agrochemicals, capitalizing on its ability to inhibit biofilm formation, which can be beneficial in controlling microbial growth in agricultural settings.
Used as an Antibacterial Agent:
2-Aminoimidazole is employed as an antibacterial agent for its capacity to inhibit biofilm formation and disrupt bacterial cell membranes, offering a potential solution for combating bacterial infections.
Used as an Antifungal Agent:
2-Aminoimidazole is also used as an antifungal agent, leveraging its ability to disrupt fungal cell membranes and prevent the growth of fungi, which can be applied in both medical and agricultural contexts to control fungal infections.
Used in Antioxidant and Anti-Inflammatory Drug Development:
2-Aminoimidazole's antioxidant and anti-inflammatory properties make it a valuable component in the development of new drugs aimed at treating conditions associated with oxidative stress and inflammation.

Check Digit Verification of cas no

The CAS Registry Mumber 7720-39-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,2 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 7720-39:
(6*7)+(5*7)+(4*2)+(3*0)+(2*3)+(1*9)=100
100 % 10 = 0
So 7720-39-0 is a valid CAS Registry Number.
InChI:InChI=1/C3H5N3/c4-3-5-1-2-6-3/h1-2H,(H3,4,5,6)

7720-39-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1H-Imidazol-2-amine

1.2 Other means of identification

Product number -
Other names 1H-imidazol-2-amine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7720-39-0 SDS

7720-39-0Synthetic route

2-aminoimidazolesulfate
42383-61-9

2-aminoimidazolesulfate

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With sodium hydrogencarbonate In water Inert atmosphere;100%
With sodium hydroxide In methanol at 20℃;
2-azido-1H-imidazole

2-azido-1H-imidazole

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With hydrogen In ethanol at 20℃;98%
2-nitro-1H-imidazole
527-73-1

2-nitro-1H-imidazole

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With triethylamine In water at 80℃; for 4h; Inert atmosphere; Green chemistry; chemoselective reaction;91%
With palladium on activated charcoal; acetic acid In tert-butyl alcohol
2-aminoimidazole hemisulfate

2-aminoimidazole hemisulfate

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With methanol; sodium methylate at -78 - 20℃; for 4h;90%
With sodium carbonate In water at 20℃; for 0.25h;
With sodium carbonate In water at 20℃; for 3h;
2-aminoimidazole hemisulfate
1450-93-7, 36946-29-9, 42383-61-9

2-aminoimidazole hemisulfate

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With sodium carbonate In water79%
With sodium hydroxide In water
2-methyl-isourea
2440-60-0

2-methyl-isourea

2,2-dimethoxyethylamine
22483-09-6

2,2-dimethoxyethylamine

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
Stage #1: 2-methyl-isourea; 2,2-dimethoxyethylamine In water at 20 - 50℃; for 6h; Inert atmosphere;
Stage #2: With hydrogenchloride In water at 90℃; for 10h; Inert atmosphere;
74.9%
CYANAMID
420-04-2

CYANAMID

Glycolaldehyde
141-46-8

Glycolaldehyde

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With ammonium dihydrogen phosphate; ammonium bicarbonate In water at 60℃; for 1.5h; pH=Ca. 5.3; pH-value;41%
(2,2-diethoxy-ethyl)-guanidine; acetate

(2,2-diethoxy-ethyl)-guanidine; acetate

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With hydrogenchloride
2-nitro-1H-imidazole
527-73-1

2-nitro-1H-imidazole

A

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

B

2-(Hydroxyamino)imidazole
102998-00-5

2-(Hydroxyamino)imidazole

C

2-amino-4,5-dihydro-4,5-dihydroxyimidazolium chloride

2-amino-4,5-dihydro-4,5-dihydroxyimidazolium chloride

Conditions
ConditionsYield
With phosphoric acid; sodium formate In water-d2 Product distribution; Irradiation; acid reduction;A 70 % Spectr.
B n/a
C 30 % Spectr.
2-arylazo-imidazolene

2-arylazo-imidazolene

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
durch Reduktion;
2-phenylazo-imidazole

2-phenylazo-imidazole

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With hydrogenchloride; tin(ll) chloride
<4-bromo-benzen>-<1 azo 2>-imidazole

<4-bromo-benzen>-<1 azo 2>-imidazole

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With hydrogenchloride; tin(ll) chloride
hydrogenchloride
7647-01-0

hydrogenchloride

2-(p-tolylazo)imidazole
34938-48-2

2-(p-tolylazo)imidazole

tin (II)-chloride

tin (II)-chloride

A

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

B

ammonia
7664-41-7

ammonia

C

p-toluidine
106-49-0

p-toluidine

D

guanidine nitrate
113-00-8

guanidine nitrate

hydrogenchloride
7647-01-0

hydrogenchloride

2-(4-ethoxy-phenylazo)-1H-imidazole
93937-81-6

2-(4-ethoxy-phenylazo)-1H-imidazole

tin (II)-chloride

tin (II)-chloride

A

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

B

4-Ethoxyaniline
156-43-4

4-Ethoxyaniline

hydrogenchloride
7647-01-0

hydrogenchloride

2-(phenylazo)-1H-imidazole
34938-47-1

2-(phenylazo)-1H-imidazole

tin dichloride

tin dichloride

A

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

B

guanidine nitrate
113-00-8

guanidine nitrate

C

aniline
62-53-3

aniline

D

4-(4-amino-phenyl)-1(3)H-imidazol-2-ylamine
96139-65-0

4-(4-amino-phenyl)-1(3)H-imidazol-2-ylamine

hydrogenchloride
7647-01-0

hydrogenchloride

2-(4-bromo-phenylazo)-1H-imidazole
93937-76-9

2-(4-bromo-phenylazo)-1H-imidazole

tin dichloride

tin dichloride

A

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

B

4-bromo-aniline
106-40-1

4-bromo-aniline

C

4-(4-amino-phenyl)-1(3)H-imidazol-2-ylamine
96139-65-0

4-(4-amino-phenyl)-1(3)H-imidazol-2-ylamine

D

2-<5-bromo-2-amino-anilino>-imidazole

2-<5-bromo-2-amino-anilino>-imidazole

hydrogenchloride
7647-01-0

hydrogenchloride

4-(1H-imidazol-2-ylazo)-benzenesulfonic acid
108106-91-8

4-(1H-imidazol-2-ylazo)-benzenesulfonic acid

tin (II)-chloride

tin (II)-chloride

A

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

B

4-aminobenzene sulfonic acid
121-57-3

4-aminobenzene sulfonic acid

acetoacetamido
5977-14-0

acetoacetamido

3-nitro-benzaldehyde
99-61-6

3-nitro-benzaldehyde

A

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

B

α-acetyl-3-nitrocrotonamide

α-acetyl-3-nitrocrotonamide

Conditions
ConditionsYield
With acetic acid In piperidine; isopropyl alcohol
guanosine-5'-phosphoro-(2-aminoimidazole)

guanosine-5'-phosphoro-(2-aminoimidazole)

A

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

B

guanosine 5'-monophosphate disodium
5550-12-9

guanosine 5'-monophosphate disodium

Conditions
ConditionsYield
With trimethyl phosphite; water; sodium chloride; magnesium chloride; N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid In water-d2 at 25℃; Kinetics;
CYANAMID
420-04-2

CYANAMID

Glycolaldehyde
141-46-8

Glycolaldehyde

A

2-amino-1,3-oxazole
4570-45-0

2-amino-1,3-oxazole

B

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With ammonium chloride; sodium phosphate In water at 60℃; for 1h; pH=7; pH-value;A 9.6 %Spectr.
B 6.6 %Spectr.
sodium cyanide
773837-37-9

sodium cyanide

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
Stage #1: sodium cyanide With ammonium chloride; sodium chloride In water at 24℃; for 24h; pH=7; Irradiation; Inert atmosphere;
Stage #2: In water-d2 at 50℃; for 3h; pH=8;
methylthiourea hemisulfate

methylthiourea hemisulfate

2,2-dimethoxyethylamine
22483-09-6

2,2-dimethoxyethylamine

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
Stage #1: methylthiourea hemisulfate; 2,2-dimethoxyethylamine In water at 75℃; for 1h;
Stage #2: With sulfuric acid In water at 95℃; for 0.5h; pH=1;
18.06 g
thiourea
17356-08-0

thiourea

2-aminoacetonitrile
540-61-4

2-aminoacetonitrile

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Conditions
ConditionsYield
With hydrogenchloride; potassium cyanide; sodium dihydrogenphosphate; sodium hydroxide; potassium hexacyanoferrate(III) In water; water-d2
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

2-amino-1-(tert-butoxycarbonyl)imidazole
929568-19-4

2-amino-1-(tert-butoxycarbonyl)imidazole

Conditions
ConditionsYield
With sodium hydroxide In dichloromethane; water at 20℃; for 14h; Inert atmosphere;100%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

N,N-dimethyl-formamide dimethyl acetal
4637-24-5

N,N-dimethyl-formamide dimethyl acetal

2-[(dimethylamino)methylene]aminoimidazole
164583-72-6

2-[(dimethylamino)methylene]aminoimidazole

Conditions
ConditionsYield
With sodium carbonate at 20℃;95%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

carbon monoxide
201230-82-2

carbon monoxide

1-Bromo-4-fluorobenzene
460-00-4

1-Bromo-4-fluorobenzene

4-fluoro-N-(1H-imidazol-2-yl)benzamide
1128139-34-3

4-fluoro-N-(1H-imidazol-2-yl)benzamide

Conditions
ConditionsYield
With dichlorobis[benzyldiphenylphosphine]palladium(II); caesium carbonate In tetrahydrofuran at 120℃; under 6205.94 Torr; for 0.5h; Microwave irradiation;90%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

(Z)-2-bromo-3-(3-chlorophenyl)acrylaldehyde
1352755-79-3

(Z)-2-bromo-3-(3-chlorophenyl)acrylaldehyde

5-(3-chlorophenyl)imidazo[1,2-a]pyrimidine

5-(3-chlorophenyl)imidazo[1,2-a]pyrimidine

Conditions
ConditionsYield
With tert.-butylhydroperoxide; 2-(Dimethylamino)pyridine In 1,4-dioxane at 120℃; for 4h; Sealed tube; Green chemistry;90%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-chloromethyl-2-thiophenecarboxamide
229335-21-1

3-chloro-N-[4-chloro-2-[[(5-chloro-2-pyridinyl)amino]carbonyl]-6-methoxyphenyl]-4-chloromethyl-2-thiophenecarboxamide

N-(5-chloropyridin-2-yl)-2-[((4-((2-aminoimidazol-1-yl)methyl)-3-chlorothiophen-2-yl)carbonyl)amino]-3-methoxy-5-chlorobenzamide
229336-78-1

N-(5-chloropyridin-2-yl)-2-[((4-((2-aminoimidazol-1-yl)methyl)-3-chlorothiophen-2-yl)carbonyl)amino]-3-methoxy-5-chlorobenzamide

Conditions
ConditionsYield
In N,N-dimethyl-formamide at 0 - 20℃;87%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

2-((5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)acetic acid
97980-71-7

2-((5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)acetic acid

2-((5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-N-(1H-imidazol-2-yl)acetamide

2-((5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)-N-(1H-imidazol-2-yl)acetamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 20℃; for 1.25h;86%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

2-((4-oxo-2-phenyl-4H-chromen-7-yl)oxy)acetic acid
97980-65-9

2-((4-oxo-2-phenyl-4H-chromen-7-yl)oxy)acetic acid

N-(1H-imidazol-2-yl)-2-((4-oxo-2-phenyl-4H-chromen-7-yl)oxy)acetamide

N-(1H-imidazol-2-yl)-2-((4-oxo-2-phenyl-4H-chromen-7-yl)oxy)acetamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 20℃; for 1.25h;85%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

3-oxo-N-{4-[(pyrimidin-2-ylamino)sulphonyl]phenyl}butanamide
134477-88-6

3-oxo-N-{4-[(pyrimidin-2-ylamino)sulphonyl]phenyl}butanamide

(E)-2-(2-(1H-imidazol-2-yl)hydrazono)-3-oxo-N-(4-(Npyrimidin-2-ylsulfamoyl)phenyl)butanamide

(E)-2-(2-(1H-imidazol-2-yl)hydrazono)-3-oxo-N-(4-(Npyrimidin-2-ylsulfamoyl)phenyl)butanamide

Conditions
ConditionsYield
Stage #1: 1H-imidazol-2-amine With hydrogenchloride; sodium nitrite In water at 0 - 5℃;
Stage #2: 3-oxo-N-{4-[(pyrimidin-2-ylamino)sulphonyl]phenyl}butanamide With pyridine In water
85%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

6-fluoro-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-4H-1-benzopyran-4-one
1384665-31-9

6-fluoro-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-4H-1-benzopyran-4-one

4-fluoro-2-{6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]imidazo[1,2-a]pyrimidin-5-yl}phenol
1384665-24-0

4-fluoro-2-{6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]imidazo[1,2-a]pyrimidin-5-yl}phenol

Conditions
ConditionsYield
With sodium methylate In dimethyl sulfoxide at 100℃; for 0.333333 - 0.5h;84%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Camphorsulfonyl chloride
21286-54-4

Camphorsulfonyl chloride

N-(2-imidazolyl)camphor-10-sulfonamide

N-(2-imidazolyl)camphor-10-sulfonamide

Conditions
ConditionsYield
With dmap In acetonitrile at 0℃; for 1h; Inert atmosphere;83%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

7-methoxyquinoline-3-carboxylic acid
474659-26-2

7-methoxyquinoline-3-carboxylic acid

N-(1H-imidazol-2-yl)-7-methoxyquinoline-3-carboxamide

N-(1H-imidazol-2-yl)-7-methoxyquinoline-3-carboxamide

Conditions
ConditionsYield
Stage #1: 7-methoxyquinoline-3-carboxylic acid With N-ethyl-N,N-diisopropylamine; N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate In N,N-dimethyl-formamide at 20℃; for 0.0833333h;
Stage #2: 1H-imidazol-2-amine In N,N-dimethyl-formamide
81%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

(Z)-2-bromo-3-(2-methoxyphenyl)acrylaldehyde

(Z)-2-bromo-3-(2-methoxyphenyl)acrylaldehyde

5-(2-methoxyphenyl)imidazo[1,2-a]pyrimidine

5-(2-methoxyphenyl)imidazo[1,2-a]pyrimidine

Conditions
ConditionsYield
With tert.-butylhydroperoxide; 2-(Dimethylamino)pyridine In 1,4-dioxane at 120℃; for 4h; Sealed tube; Green chemistry;81%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-4H-1-benzopyran-4-one

3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-4H-1-benzopyran-4-one

2-{6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]imidazo[1,2-a]pyrimidin-5-yl}phenol
1384665-23-9

2-{6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]imidazo[1,2-a]pyrimidin-5-yl}phenol

Conditions
ConditionsYield
With sodium methylate In dimethyl sulfoxide at 100℃; for 0.333333 - 0.5h;78%
pyridine-2-carbaldehyde
1121-60-4

pyridine-2-carbaldehyde

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

Diethyl methylphosphonate
683-08-9

Diethyl methylphosphonate

4-fluorobenzonitrile
1194-02-1

4-fluorobenzonitrile

5-(4-fluoro-phenyl)-7-pyridin-2-yl-imidazo[1,2-a]pyrimidine

5-(4-fluoro-phenyl)-7-pyridin-2-yl-imidazo[1,2-a]pyrimidine

Conditions
ConditionsYield
Stage #1: Diethyl methylphosphonate; 4-fluorobenzonitrile With n-butyllithium In tetrahydrofuran; hexane at -78 - -50℃; for 0.5h;
Stage #2: pyridine-2-carbaldehyde In tetrahydrofuran; hexane at -50 - 0℃; for 0.75h;
Stage #3: 1H-imidazol-2-amine In tetrahydrofuran; N,N-dimethyl-formamide for 8h; Heating;
77%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

phthalic anhydride
85-44-9

phthalic anhydride

2-Phthalimidoimidazole
185563-91-1

2-Phthalimidoimidazole

Conditions
ConditionsYield
at 170℃; for 0.25h; Condensation;75%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

3-(dimethylamino)-1-phenyl-2-(pyridine-2-yl)prop-2-en-1-one

3-(dimethylamino)-1-phenyl-2-(pyridine-2-yl)prop-2-en-1-one

7-phenyl-6-(pyridin-2-yl)imidazo[1,2-a]pyrimidine

7-phenyl-6-(pyridin-2-yl)imidazo[1,2-a]pyrimidine

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide for 6h; Reflux;75%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

(Z)-2-bromo-3-(4-(dimethylamino)phenyl)acrylaldehyde

(Z)-2-bromo-3-(4-(dimethylamino)phenyl)acrylaldehyde

4-(imidazo[1,2-a]pyrimidin-5-yl)-N,N-dimethylaniline

4-(imidazo[1,2-a]pyrimidin-5-yl)-N,N-dimethylaniline

Conditions
ConditionsYield
With tert.-butylhydroperoxide; 2-(Dimethylamino)pyridine In 1,4-dioxane at 120℃; for 4h; Sealed tube; Green chemistry;74%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

C10H6BrF3O

C10H6BrF3O

5-(3-(trifluoromethyl)phenyl)imidazo[1,2-a]pyrimidine

5-(3-(trifluoromethyl)phenyl)imidazo[1,2-a]pyrimidine

Conditions
ConditionsYield
With tert.-butylhydroperoxide; 2-(Dimethylamino)pyridine In 1,4-dioxane at 120℃; for 4h; Sealed tube; Green chemistry;74%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

3,3-dimethoxy-2-formyl-propanenitrile sodium salt
105161-33-9

3,3-dimethoxy-2-formyl-propanenitrile sodium salt

imidazo(1,2-a)pyrimidine-6-carbonitrile

imidazo(1,2-a)pyrimidine-6-carbonitrile

Conditions
ConditionsYield
Stage #1: 1H-imidazol-2-amine; 3,3-dimethyloxy-2-formylpropionitrile sodium salt With hydrogenchloride In methanol; water at 20℃; for 4h;
Stage #2: With hydrogenchloride In methanol; water at 20℃; for 12h; regioselective reaction;
73%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

methyl iodide
74-88-4

methyl iodide

1-methyl-2-aminoimidazole
6646-51-1

1-methyl-2-aminoimidazole

Conditions
ConditionsYield
With copper(l) iodide; 8-quinolinol; sodium t-butanolate In methanol at 50℃; for 36h; Solvent;72%
Stage #1: 1H-imidazol-2-amine With tert-butyldimethylsilyl chloride
Stage #2: methyl iodide With n-butyllithium
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

1-[2-(3,4-dichloro-benzoyl)-4,5-dimethoxy-phenyl]-propan-2-one

1-[2-(3,4-dichloro-benzoyl)-4,5-dimethoxy-phenyl]-propan-2-one

1-(3,4-dichloro-phenyl)-2-(1H-imidazol-2-yl)-6,7-dimethoxy-3-methyl-isoquinolinium; chloride

1-(3,4-dichloro-phenyl)-2-(1H-imidazol-2-yl)-6,7-dimethoxy-3-methyl-isoquinolinium; chloride

Conditions
ConditionsYield
With hydrogenchloride In acetonitrile for 3h; Heating;72%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

pyridine-3-carbonitrile
100-54-9

pyridine-3-carbonitrile

Diethyl methylphosphonate
683-08-9

Diethyl methylphosphonate

4-fluorobenzaldehyde
459-57-4

4-fluorobenzaldehyde

7-(4-fluoro-phenyl)-5-pyridin-3-yl-imidazo[1,2-a]pyrimidine

7-(4-fluoro-phenyl)-5-pyridin-3-yl-imidazo[1,2-a]pyrimidine

Conditions
ConditionsYield
Stage #1: pyridine-3-carbonitrile; Diethyl methylphosphonate With n-butyllithium In tetrahydrofuran; hexane at -78 - -50℃; for 0.5h;
Stage #2: 4-fluorobenzaldehyde In tetrahydrofuran; hexane at -50 - 0℃; for 0.75h;
Stage #3: 1H-imidazol-2-amine In tetrahydrofuran; N,N-dimethyl-formamide for 8h; Heating;
72%
furfural
98-01-1

furfural

1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

isopropyl acetoacetate
542-08-5

isopropyl acetoacetate

(±)-isopropyl 5-(furan-2-yl)-7-methyl-5,8-dihydroimidazo[1,2-a]pyrimidine-6-carboxylate

(±)-isopropyl 5-(furan-2-yl)-7-methyl-5,8-dihydroimidazo[1,2-a]pyrimidine-6-carboxylate

Conditions
ConditionsYield
With chloroacetic acid In tetrahydrofuran at 80℃; for 12h; Biginelli Pyrimidone Synthesis; Sealed tube;72%
1H-imidazol-2-amine
7720-39-0

1H-imidazol-2-amine

propionyl chloride
79-03-8

propionyl chloride

1-(2-amino-1H-imidazol-1-yl)propyl-1-one

1-(2-amino-1H-imidazol-1-yl)propyl-1-one

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at -20℃; for 2h;72%

7720-39-0Relevant academic research and scientific papers

2-Aminoimidazole amino acids as inhibitors of the binuclear manganese metalloenzyme human arginase i

Ilies, Monica,Di Costanzo, Luigi,North, Michelle L.,Scott, Jeremy A.,Christianson, David W.

, p. 4266 - 4276 (2010)

Arginase, a key metalloenzyme of the urea cycle that converts l-arginine into l-ornithine and urea, is presently considered a pharmaceutical target for the management of diseases associated with aberrant l-arginine homeostasis, such as asthma, cardiovascular diseases, and erectile dysfunction. We now report the design, synthesis, and evaluation of a series of 2-aminoimidazole amino acid inhibitors in which the 2-aminoimidazole moiety serves as a guanidine mimetic. These compounds represent a new class of arginase inhibitors. The most potent inhibitor identified in this study, 2-(S)-amino-5-(2-aminoimidazol-1-yl) pentanoic acid (A1P, 10), binds to human arginase I with Kd = 2 μM and significantly attenuates airways hyperresponsiveness in a murine model of allergic airways inflammation. These findings suggest that 2-aminoimidazole amino acids represent new leads for the development of arginase inhibitors with promising pharmacological profiles.

A continuous reaction network that produces RNA precursors

Adam, Zachary R.,Ali, Sarfaraz,Cleaves, H. James,Fahrenbach, Albert C.,Tran, Quoc Phuong,Yi, Ruiqin,Yoda, Isao

, p. 13267 - 13274 (2020)

Continuous reaction networks, which do not rely on purification or timely additions of reagents, serve as models for chemical evolution and have been demonstrated for compounds thought to have played important roles for the origins of life such as amino acids, hydroxy acids, and sugars. Step-by-step chemical protocols for ribonucleotide synthesis are known, but demonstrating their synthesis in the context of continuous reaction networks remains a major challenge. Herein, compounds proposed to be important for prebiotic RNA synthesis, including glycolaldehyde, cyanamide, 2-aminooxazole, and 2-aminoimidazole, are generated from a continuous reaction network, starting from an aqueous mixture of NaCl, NH4Cl, phosphate, and HCN as the only carbon source. No well-timed addition of any other reagents is required. The reaction network is driven by a combination of γ radiolysis and dry-down. γ Radiolysis results in a complex mixture of organics, including the glycolaldehyde-derived glyceronitrile and cyanamide. This mixture is then dried down, generating free glycolaldehyde that then reacts with cyanamide/NH3 to furnish a combination of 2-aminooxazole and 2-aminoimidazole. This continuous reaction network models how precursors for generating RNA and other classes of compounds may arise spontaneously from a complex mixture that originates from simple reagents.

Photoredox chemistry in the synthesis of 2-aminoazoles implicated in prebiotic nucleic acid synthesis

Liu, Ziwei,Wu, Long-Fei,Bond, Andrew D.,Sutherland, John D.

supporting information, p. 13563 - 13566 (2020/11/17)

Prebiotically plausible ferrocyanide-ferricyanide photoredox cycling oxidatively converts thiourea to cyanamide, whilst HCN is reductively homologated to intermediates which either react directly with the cyanamide giving 2-aminoazoles, or have the potential to do so upon loss of HCN from the system. Thiourea itself is produced by heating ammonium thiocyanate, a product of the reaction of HCN and hydrogen sulfide under UV irradiation. This journal is

Synthesis and Antitrypanosomal Activity of 1,4-Disubstituted Triazole Compounds Based on a 2-Nitroimidazole Scaffold: a Structure-Activity Relationship Study

Assun??o, Elvis L. F.,Carvalho, Diego B.,das Neves, Amarith R.,Kawasoko Shiguemotto, Cristiane Y.,Portapilla, Gisele B.,de Albuquerque, Sergio,Baroni, Adriano C. M.

, p. 2019 - 2028 (2020/09/21)

Chagas disease affects 6–8 million people worldwide, remaining a public health concern. Toxicity, several adverse effects and inefficiency in the chronic stage of the disease are the major challenges regarding the available treatment protocols. This work involved the synthesis of twenty-two 1,4-disubstituted-1,2,3-triazole analogues of benznidazole (BZN), by using a click chemistry strategy. Analogues were obtained in moderate to good yields (40-97 %). Antitrypanosomal activity was evaluated against the amastigote forms of Trypanosoma cruzi. Compound 8 a (4-(2-nitro-1H-imidazol-1-yl)methyl)-1-phenyl-1H-1,2,3-triazole) without substituents on phenyl ring showed similar biological activity to BZN (IC50=3.0 μM, SI>65.3), with an IC50=3.1 μM and SI>64.5. Compound 8 o (3,4-di-OCH3?Ph) with IC50 = 0.65 μM was five-fold more active than BZN, and showed an excellent selectivity index (SI>307.7). Compound 8 v (3-NO2, 4-CH3?Ph) with IC50=1.2 μM and relevant SI>166.7, also exhibited higher activity than BZN. SAR analysis exhibited a pattern regarding antitrypanosomal activity relative to BZN, in compounds with electron-withdrawing groups (Hammett σ+) at position 3, and electron-donating groups (Hammett σ-) at position 4, as observed in 8 o and 8 v. Further research might explore in vivo antitrypanosomal activity of promising analogues 8 a, 8 o, and 8 v. Overall, this study indicates that approaches such as the bioisosteric replacement of amide group by 1,2,3-triazole ring, the use of click chemistry as a synthesis strategy, and design tools like Craig-plot and Topliss tree are promising alternatives to drug discovery.

Rational design of nickel catalysts containing N-acylated imidazolin-2-imine ligand for ethylene copolymerization with polar monomer

Li, Yanqing,Cheng, Hailong,Xiao, Ru,Cai, Zhengguo

, p. 117 - 123 (2020/02/04)

By taking advantage of electronic influence of ligand design, the novel neutral nickel complexes bearing strong electron-donating N-acylated imidazolin-2-imine ligand were synthesized and characterized. The nickel catalysts conducted ethylene polymerization with high activity and good thermal stability, affording semicrystalline polyethylene with short chain branches (32–46/1000 C atoms). The complex Ni2 bearing adamantyl substituent on the imidazoline ligand showed higher activity than phenyl substituted complex Ni1, and highest activity was observed at 60 °C (up to ~106 g?mol?1?h?1). Most importantly, the catalysts were also effective for the copolymerization of ethylene and 5-hexenyl acetate with moderate activity (~105 g?mol?1?h?1). The microstructure analyses by the 13C NMR spectroscopy indicated that the 5-hexenyl acetate was successfully incorporated into the polyethylene main chain with reasonable comonomer content.

Keto-imidazoline-2-imine ligand [N,O] bidentate nickel and palladium complex as well as preparation method and application thereof

-

Paragraph 0082; 0086; 0094; 0098; 0106; 0110; 0118; 0122, (2019/11/13)

The invention relates to a keto-imidazoline-2-imine [N,O] bidentate nickel and palladium complex as well as a preparation method and application thereof. The preparation method comprises the followingsteps: reacting a keto-imidazoline-2-imine ligand with a hydrogen withdrawing reagent and a metal precursor in sequence to prepare a keto-imidazoline-2-imine [N,O] bidentate nickel and palladium complex; and the structural formula of the prepared complex is one of formulas shown in the specification. The complex and a cocatalyst form a catalyst composition, the complex or the catalyst compositionis used for catalyzing homopolymerization or copolymerization of olefin monomers, and the specific process is as follows: under the protection of nitrogen, firstly dissolving the complex or the catalyst composition in a solvent, then adding an olefin monomer, and conducting reacting for a period of time at a certain temperature and under a certain pressure to prepare the olefin polymer. The complex and the catalyst composition provided by the invention have relatively high catalytic activity, high tolerance to polar monomers and relatively low application cost.

PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

-

Page/Page column 497-498, (2018/09/21)

Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, and Formula IV or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

Common and Potentially Prebiotic Origin for Precursors of Nucleotide Synthesis and Activation

Fahrenbach, Albert C.,Giurgiu, Constantin,Tam, Chun Pong,Li, Li,Hongo, Yayoi,Aono, Masashi,Szostak, Jack W.

supporting information, p. 8780 - 8783 (2017/07/12)

We have recently shown that 2-aminoimidazole is a superior nucleotide activating group for nonenzymatic RNA copying. Here we describe a prebiotic synthesis of 2-aminoimidazole that shares a common mechanistic pathway with that of 2-aminooxazole, a previously described key intermediate in prebiotic nucleotide synthesis. In the presence of glycolaldehyde, cyanamide, phosphate and ammonium ion, both 2-aminoimidazole and 2-aminooxazole are produced, with higher concentrations of ammonium ion and acidic pH favoring the former. Given a 1:1 mixture of 2-aminoimidazole and 2-aminooxazole, glyceraldehyde preferentially reacts and cyclizes with the latter, forming a mixture of pentose aminooxazolines, and leaving free 2-aminoimidazole available for nucleotide activation. The common synthetic origin of 2-aminoimidazole and 2-aminooxazole and their distinct reactivities are suggestive of a reaction network that could lead to both the synthesis of RNA monomers and to their subsequent chemical activation.

Enhanced nonenzymatic RNA copying with 2-aminoimidazole activated nucleotides

Li, Li,Prywes, Noam,Tam, Chun Pong,Oflaherty, Derek K.,Lelyveld, Victor S.,Izgu, Enver Cagri,Pal, Ayan,Szostak, Jack W.

supporting information, p. 1810 - 1813 (2017/02/15)

Achieving efficient nonenzymatic replication of RNA is an important step toward the synthesis of self-replicating protocells that may mimic early forms of life. Despite recent progress, the nonenzymatic copying of templates containing mixed sequences remains slow and inefficient. Here we demonstrate that activating nucleotides with 2-aminoimidazole results in superior reaction kinetics and improved yields of primer extension reaction products. This new leaving group significantly accelerates monomer addition as well as trimer-assisted RNA primer extension, allowing efficient copying of a variety of short RNA templates with mixed sequences.

Polymethylhydrosiloxane derived palladium nanoparticles for chemo- and regioselective hydrogenation of aliphatic and aromatic nitro compounds in water

Damodara, Dandu,Arundhathi, Racha,Ramesh Babu, T. Venkata,Legan, Margaret K.,Kumpaty, Hephzibah J.,Likhar, Pravin R.

, p. 22567 - 22574 (2014/06/23)

Chemo- and regioselective hydrogenation of a wide range of aliphatic, unsaturated, aromatic and heteroaromatic nitro compounds into their corresponding amines has been achieved with highly efficient polysiloxane-stabilised "Pd" nanoparticles on NAP-magnesium oxide supports using an environmentally friendly hydrogenating agent, polymethylhydrosiloxane [PMHS] in water. Highly stable and active Pd nanoparticles were prepared by the reduction of NAP-Mg-PdCl4 with PMHS, which serves as a reducing agent as well as a capping agent. The well-dispersed palladium nanoparticles on NAP-MgO catalysts also exhibit excellent regioselectivity in the hydrogenation of dinitrobenzenes to the corresponding nitroanilines. The catalyst has high durability against sintering during the hydrogenation reaction and can be reused with no loss in its activity. This journal is the Partner Organisations 2014.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7720-39-0